SCHEDULE 13D/A: Engine Capital Group Increases Stake in Orthofix Medical to 9.3%
Schedule 13D/A Amendment
Engine Capital and its affiliates have significantly increased their beneficial ownership in Orthofix Medical Inc., now holding an aggregate of 9.3% of the company's common stock.
Summary
- Engine Capital Management, LP, along with its affiliates Engine Capital, L.P., Engine Jet Capital, L.P., and Engine Lift Capital, LP, collectively reported beneficial ownership of 3,628,227 shares of Orthofix Medical Inc. common stock.
- This aggregate ownership represents approximately 9.3% of Orthofix Medical Inc.'s outstanding shares, based on 39,022,492 shares outstanding as of February 21, 2025.
- Engine Capital, L.P. directly owns 3,015,343 shares (7.7%), acquired for an aggregate purchase price of approximately $37,024,111.
- Engine Jet Capital, L.P. directly owns 303,318 shares (0.8%), acquired for approximately $3,569,845.
- Engine Lift Capital, LP directly owns 309,566 shares (0.8%), acquired for approximately $3,705,602.
- All shares were purchased using working capital, which may include margin loans.
- Recent purchases by Engine Capital, L.P. include 50,000 shares at $16.9025 on January 10, 2025, and multiple transactions in late February 2025 at prices ranging from $17.0902 to $17.1268.
- Engine Jet Capital, L.P. made purchases on February 26 and 27, 2025, at prices around $17.1144 and $17.0902.
- Engine Lift Capital, LP also made purchases in late February 2025, with prices similar to those of Engine Jet Capital.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive. An increase in a significant investor's stake, especially by an entity like Engine Capital known for activist investing, can be seen as a positive signal of potential value unlocking or confidence in the company's future, even if no specific activist agenda is stated in this filing.
Positives
- A significant increase in beneficial ownership by an investment group like Engine Capital can signal confidence in the company's future prospects.
- The continued accumulation of shares by Engine Capital and its affiliates suggests a long-term investment strategy or potential activist interest, which could drive value creation.
Risks
- The filing does not specify the purpose of the acquisition beyond investment, which could lead to speculation regarding potential activist intentions or demands on management.
- The use of margin loans for share purchases, as disclosed, introduces financial leverage risk for the reporting persons, though not directly for Orthofix Medical Inc.
Future Outlook
This Schedule 13D/A filing primarily reports changes in beneficial ownership and does not contain forward-looking statements or guidance from Orthofix Medical Inc. or the reporting persons regarding the company's future operations or financial performance.
Industry Context
This filing indicates a significant accumulation of shares by an investment firm in the medical device sector. Such filings often precede or accompany increased shareholder engagement or potential activist campaigns, which are common in industries undergoing consolidation, strategic shifts, or perceived undervaluation.
Stakeholder Impact
- Shareholders: The increased stake by Engine Capital could lead to enhanced shareholder advocacy, potentially influencing corporate strategy, governance, or capital allocation decisions, which may impact share value.
- Management and Board: The significant ownership by Engine Capital may lead to increased scrutiny or engagement from the investor regarding company performance and strategic direction.
Next Steps
- The reporting persons may continue to acquire or dispose of shares of Orthofix Medical Inc. common stock.
- The reporting persons may engage in discussions with Orthofix Medical Inc.'s management, board of directors, or other shareholders regarding the company's business, operations, governance, or strategic plans.
Key Dates
| Date | Description |
|---|---|
| 01/10/2025 | Engine Capital, L.P. purchased 50,000 shares of Common Stock at $16.9025 per share. |
| 02/21/2025 | Total number of Orthofix Medical Inc. shares outstanding reported as 39,022,492. |
| 02/25/2025 | Date of event requiring the filing of this Schedule 13D/A statement; Engine Capital, L.P. purchased 68,553 and 21,877 shares at $17.1268; Engine Lift Capital, LP purchased 2,247 shares at $17.1268. |
| 02/26/2025 | Engine Capital, L.P. purchased 7,309 and 13,726 shares at $17.1144; Engine Jet Capital, L.P. purchased 1,381 shares at $17.1144; Engine Lift Capital, LP purchased 612 and 1,410 shares at $17.1144. |
| 02/27/2025 | Engine Capital, L.P. purchased 686 and 8,047 shares at $17.0902; Engine Jet Capital, L.P. purchased 809 shares at $17.0902; Engine Lift Capital, LP purchased 826 shares at $17.0902. |
| 02/27/2024 | Signature date for the Schedule 13D/A filing. |
Recommendation
holdKeywords
Orthofix Medical Inc., Engine Capital, Schedule 13D/A, Beneficial Ownership, Share Acquisition, Medical Devices, Healthcare, Investment, Activist Investor, OFX
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.